Steris Corp (STE) Stock Price, Quote & News

Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in proced...

Industry: Medical Devices

Sector: Healthcare

Phone: 440 354 2600

Website: www.steris.com

Address:

5960 Heisley Road, Mentor, United States

EarningsInsider May. 12 at 2:01 PM

https://www.marketbeat.com/earnings/reports/2026-5-11-steris-plc-stock/ $STE STERIS Earnings Transcript

0 · Reply

StocktwitsEarnings May. 11 at 8:45 PM

$STE Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $2.25 up 52.03% YoY • Reported revenue of $1.59B up 7.28% YoY • STERIS anticipates fiscal 2027 as reported revenue to increase 7-8% and adjusted diluted EPS to range from $11.10 to $11.30, an increase of 9-11%. Free cash flow is expected to be approximately $850 million for Steris Plc.

0 · Reply

DonCorleone77 May. 11 at 8:43 PM

$STE Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08 Sees FY27 revenue growth 7%-8% from $5.9B, consensus $6.31B. Sees FY27 CapEx $375M.

0 · Reply

DonCorleone77 May. 11 at 8:40 PM

$STE Steris reports Q4 adjusted EPS $2.83, consensus $2.85 Reports Q4 revenue $1.6B, consensus $1.6B. "FY26 was another record year," said CEO Dan Carestio. "Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associates who continue to put our Customers first. As we look ahead, we are excited for what is to come as we capitalize on our unique ability to help our Customers enable procedural growth, deliver quality outcomes and drive compliance with standardization and optimization."

0 · Reply

Huck18 May. 11 at 8:36 PM

$STE A miss and a Rise, vs. last Q the opposite ... Funny but Expected at this low price

0 · Reply

1986iamwallstreet May. 11 at 8:35 PM

$STE Steris Q4 Adj. EPS $2.83 Misses $2.85 Estimate, Sales $1.588B Miss $1.595B Estimate Double miss

0 · Reply

BillionerOfKing May. 11 at 3:59 PM

$STE Current Stock Price: $202.84 Contracts to trade: $210.0 STE May 15 2026 Call Entry: $2.50 Exit: $3.33 ROI: 33% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Parlandoconme May. 10 at 10:59 AM

$TOMZ This company has serious upside based on the earnings conference call. Decon chambers,robo rides,bio lab decon,food security. Unlimited. $STE

0 · Reply

BillionerOfKing May. 6 at 10:21 PM

$STE Current Stock Price: $214.52 Contracts to trade: $220.0 STE May 15 2026 Call Entry: $2.90 Exit: $4.75 ROI: 64% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 6 at 6:54 PM

$STE Price: $214.29 (+0.62%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.76% RSI: 42.9 | Momentum: Moderate Volume: -60.2% vs avg Volatility: 1.49% Support: $209.61 | Resistance: $227.87 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

Steris price target lowered to $269 from $291 at KeyBanc

May 12, 2026, 9:00 AM EDT - 1 day ago

STERIS Earnings Call Transcript: Q4 2026

2026-05-11T23:52:15.000Z - 1 day ago

Steris reports Q4 adjusted EPS $2.83, consensus $2.85

2026-05-11T23:43:33.000Z - 1 day ago

Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08

May 11, 2026, 6:33 PM EDT - 1 day ago

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

May 11, 2026, 4:30 PM EDT - 1 day ago

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

May 7, 2026, 4:30 PM EDT - 5 days ago

STERIS Appoints Pierre Boulud to Board of Directors

May 5, 2026, 4:30 PM EDT - 7 days ago

STERIS Announces Dividend of $0.63 per share

Apr 21, 2026, 4:30 PM EDT - 21 days ago

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

Feb 5, 2026, 9:00 AM EST - 3 months ago

STERIS Earnings Call Transcript: Q3 2026

2026-02-04T21:40:54.000Z - 3 months ago

Steris sees FY26 adjusted EPS $10.15-$10.30, consensus $10.21

2026-02-04T21:35:27.000Z - 3 months ago

Steris reports Q3 adjusted EPS $2.53, consensus $2.53

Feb 4, 2026, 4:30 PM EST - 3 months ago

STERIS Announces Financial Results for Fiscal 2026 Third Quarter

Jan 21, 2026, 4:30 PM EST - 3 months ago

STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026

Jan 20, 2026, 4:30 PM EST - 4 months ago

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

MTD

2025-11-06T14:55:55.000Z - 6 months ago

Early notable gainers among liquid option names on November 6th

APA APD DDOG PH

Nov 6, 2025, 9:00 AM EST - 6 months ago

STERIS Earnings Call Transcript: Q2 2026

2025-11-05T23:10:53.000Z - 6 months ago

Steris raises FY26 adjusted EPS view to $10.15-$10.30 from $9.90-$10.15

2025-11-05T23:05:17.000Z - 6 months ago

Steris reports Q2 adjusted EPS $2.47, consensus $2.35

Nov 5, 2025, 4:30 PM EST - 6 months ago

STERIS Announces Financial Results for Fiscal 2026 Second Quarter

Oct 21, 2025, 4:30 PM EDT - 7 months ago

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025

2025-09-29T20:50:19.000Z - 8 months ago

Steris management to meet with Piper Sandler

2025-08-19T19:25:17.000Z - 9 months ago

Steris management to meet virtually with KeyBanc

Aug 7, 2025, 9:00 AM EDT - 9 months ago

STERIS Earnings Call Transcript: Q1 2026

2025-08-06T20:47:59.000Z - 9 months ago

Steris reports Q1 adjusted EPS $2.34, consensus $2.26

2025-08-06T20:46:50.000Z - 9 months ago

Steris affirms fiscal 2026 adjusted EPS outlook $9.90-$10.15, consensus $10.04

2025-08-06T20:45:54.000Z - 9 months ago

Steris CFO Michael Tokich stepping down, Karen Burton to succeed

Aug 6, 2025, 4:31 PM EDT - 9 months ago

STERIS Announces Chief Financial Officer Transition

Aug 6, 2025, 4:30 PM EDT - 9 months ago

STERIS Announces Financial Results for Fiscal 2026 First Quarter

2025-07-30T21:10:30.000Z - 10 months ago

Steris increases quarterly dividend to 63c per share

Jul 30, 2025, 4:30 PM EDT - 10 months ago

STERIS Raises Dividend to $0.63 per share

Jul 22, 2025, 4:30 PM EDT - 10 months ago

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

2025-07-22T12:21:43.000Z - 10 months ago

Steris price target raised to $288 from $277 at KeyBanc

2025-07-15T10:10:30.000Z - 10 months ago

Steris upgraded to Overweight from Equal Weight at Morgan Stanley

2025-06-20T21:50:07.000Z - 11 months ago

Steris awarded $450M Navy contract modification

May 20, 2025, 7:57 AM EDT - 1 year ago

U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More

May 15, 2025, 12:39 PM EDT - 1 year ago

Why This Medical Equipment Stock Is Today's S&P 500 Winner

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings Call Transcript: Q4 2025

May 14, 2025, 5:26 PM EDT - 1 year ago

Steris forecasts annual profit above estimates on strong medical equipment sales

May 14, 2025, 5:06 PM EDT - 1 year ago

Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

May 14, 2025, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

May 7, 2025, 4:30 PM EDT - 1 year ago

STERIS Declares Dividend of $0.57 per share

Apr 22, 2025, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Earnings Call Transcript: Q3 2025

Feb 5, 2025, 6:43 PM EST - 1 year ago

Steris lowers annual profit forecast due to a stronger dollar

Feb 5, 2025, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

Jan 22, 2025, 4:30 PM EST - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

Jan 21, 2025, 6:30 AM EST - 1 year ago

STERIS Announces Outcome of Ethylene Oxide Trial

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Earnings Call Transcript: Q2 2025

Nov 6, 2024, 5:44 PM EST - 1 year ago

Steris beats quarterly estimates on continued demand for medical procedures

Nov 6, 2024, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

Oct 23, 2024, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024

Oct 9, 2024, 3:39 PM EDT - 1 year ago

STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement

Sep 4, 2024, 1:50 PM EDT - 1 year ago

STERIS Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 26, 2024, 4:30 PM EDT - 1 year ago

STERIS to Present at the Morgan Stanley Healthcare Conference

Aug 7, 2024, 9:00 AM EDT - 1 year ago

STERIS Earnings Call Transcript: Q1 2025

Aug 6, 2024, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 First Quarter

Jul 31, 2024, 4:30 PM EDT - 1 year ago

STERIS Raises Dividend to $0.57 per share

Jul 23, 2024, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024

Jun 3, 2024, 7:00 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings Call Transcript: Q4 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year

May 1, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Dividend of $0.52 per share

Apr 24, 2024, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024

Apr 11, 2024, 7:30 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP

Apr 11, 2024, 6:58 AM EDT - 2 years ago

STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Earnings Call Transcript: Q3 2024

Feb 7, 2024, 6:35 PM EST - 2 years ago

Steris beats third-quarter estimates on strong medical procedure demand

Feb 7, 2024, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Third Quarter

Jan 23, 2024, 4:30 PM EST - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024

Nov 8, 2023, 9:00 AM EST - 2 years ago

STERIS Earnings Call Transcript: Q2 2024

Nov 7, 2023, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Second Quarter

Oct 24, 2023, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023

Sep 13, 2023, 8:10 AM EDT - 2 years ago

STERIS Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

Aug 2, 2023, 9:00 AM EDT - 3 years ago

STERIS Earnings Call Transcript: Q1 2024

Aug 1, 2023, 5:39 PM EDT - 3 years ago

Medical device maker Steris lifts 2024 results view, records quarterly beat

Aug 1, 2023, 4:30 PM EDT - 3 years ago

STERIS Announces Financial Results for Fiscal 2024 First Quarter

Jul 26, 2023, 4:30 PM EDT - 3 years ago

STERIS Raises Dividend to $0.52 per share

Jul 19, 2023, 4:30 PM EDT - 3 years ago

STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023

Jun 20, 2023, 8:18 AM EDT - 3 years ago

Steris paying $540 mln for BD surgical instrument unit

BDX

EarningsInsider May. 12 at 2:01 PM

https://www.marketbeat.com/earnings/reports/2026-5-11-steris-plc-stock/ $STE STERIS Earnings Transcript

0 · Reply

StocktwitsEarnings May. 11 at 8:45 PM

0 · Reply

DonCorleone77 May. 11 at 8:43 PM

$STE Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08 Sees FY27 revenue growth 7%-8% from $5.9B, consensus $6.31B. Sees FY27 CapEx $375M.

0 · Reply

DonCorleone77 May. 11 at 8:40 PM

0 · Reply

Huck18 May. 11 at 8:36 PM

$STE A miss and a Rise, vs. last Q the opposite ... Funny but Expected at this low price

0 · Reply

1986iamwallstreet May. 11 at 8:35 PM

$STE Steris Q4 Adj. EPS $2.83 Misses $2.85 Estimate, Sales $1.588B Miss $1.595B Estimate Double miss

0 · Reply

BillionerOfKing May. 11 at 3:59 PM

0 · Reply

Parlandoconme May. 10 at 10:59 AM

$TOMZ This company has serious upside based on the earnings conference call. Decon chambers,robo rides,bio lab decon,food security. Unlimited. $STE

0 · Reply

BillionerOfKing May. 6 at 10:21 PM

0 · Reply

CapitalMonk May. 6 at 6:54 PM

0 · Reply

OfficialStocktwitsUser May. 5 at 7:37 PM

$STE RSI: 39.62, MACD: -3.0713 Vol: 4.56, MA20: 220.71, MA50: 224.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ihuntbiggame Apr. 20 at 3:47 PM

$VUZI Connect more DOTS... Mr. YUTAKA, what a good looking suit & wish I still had all that hair! $HIMS? We can assume...these 3 dots are going to be released... MUFAM is a major institutional lender and investor in the pharmaceutical and medical equipment sectors. These companies use AR for remote surgical assistance, medical training, and pharmaceutical manufacturing quality control. Vertex Pharmaceuticals ($VRTX): MUFAM increased its stake in Vertex Pharmaceuticals to over 544,000 shares (valued at ~$213M) in early 2026. Vuzix tech is used in high-stakes biotech labs for hands-free data visualization during drug discovery and manufacturing processes. STERIS plc ($STE): MUFAM holds over 1.5M shares (~$387M) in STERIS, a leader in sterilization and surgical equipment. Smart glasses are used in sterile processing departments to provide step-by-step digital workflows for technicians cleaning complex surgical instruments.

2 · Reply

MonkeyPlanet Mar. 27 at 6:10 PM

$STE 🥰

0 · Reply

Ro_Patel Mar. 13 at 2:37 PM

CFRA initiates coverage on $STE & sets TP of $275

0 · Reply

Factozcentral Feb. 23 at 3:05 PM

$SPHR $STE $SSNC $STNG 👁️

0 · Reply

Estimize Feb. 19 at 9:00 PM

Wall St is expecting 2.85 EPS for $STE Q4 [Reporting 05/20 AMC] http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_cont

0 · Reply

ZacksResearch Feb. 5 at 3:01 PM

$STE’s earnings in line, but why the drop? 🤔 Q3 EPS met the Zacks Consensus Estimate at $2.53, with the revenue figure surpassing estimates by 1.1%. Yet, shares fell 3.6% post-earnings due to margin contraction concerns 📉. Complete risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2829761/ste-q3-earnings-meet-revenues-beat-stock-dips-in-aftermarket-trading?cid=sm-stocktwits-2-2829761-body-32076&ADID=SYND_STOCKTWITS_TWEET_2_2829761_BODY_32076

0 · Reply

ZacksResearch Feb. 5 at 2:01 PM

$STE just beat revenues — and the stock still sold off. ⚠️ Q3 earnings met estimates and revenues came in ahead, but shares dipped in aftermarket trading as investors zeroed in on gross margin contraction despite solid growth. See what’s really driving the market’s reaction here 👉 https://www.zacks.com/stock/news/2829761/ste-q3-earnings-meet-revenues-beat-stock-dips-in-aftermarket-trading?cid=sm-stocktwits-2-2829761-teaser-32075&ADID=SYND_STOCKTWITS_TWEET_2_2829761_TEASER_32075

0 · Reply

StocktwitsEarnings Feb. 5 at 12:00 PM

$STE Q3 '26 Earnings Results & Recap For fiscal 2026, Steris Plc expects as reported revenue from continuing operations to increase 8-9%, with adjusted EPS ranging from $10.15 to $10.30, and free cash flow anticipated at $850M.

0 · Reply

ProtocolPartners Feb. 4 at 11:30 AM

$STE is a diversified healthcare product company; its procedure kit business provides steady recurring revenue.

0 · Reply

ZacksResearch Feb. 3 at 1:03 PM

Q4 earnings season is heating up — but the setup is tricky ⚠️📊 $BSX, $ALGN, $STE, and $TECH are set to report as sector profits slow, even while revenue growth stays steady — a classic margin-vs-growth tension to watch closely. See what this earnings setup could mean for these names 👉 https://www.zacks.com/stock/news/2827637/medtech-stocks-to-watch-for-earnings-on-feb-4-bsx-algn-more?cid=sm-stocktwits-2-2827637-teaser-31608&ADID=SYND_STOCKTWITS_TWEET_2_2827637_TEASER_31608

0 · Reply

Market Cap	19.80B
Revenue (ttm)	5.46B
Net Income (ttm)	614.64M
EPS (ttm)	N/A
PE Ratio	20.58
Forward PE	18.79
Profit Margin	11.26%
Debt to Equity Ratio	0.26

Volume	441,242
Avg Vol	788,078
Day's Range	N/A - N/A
Shares Out	98.08M
Stochastic %K	68%
Beta	0.95
Analysts	Strong Sell
Price Target	$287.33